Table 5

Comparison of standardized mortality ratios with other studies
Author Country All cause SMR (95% CI) Liver related SMR (95% CI) Drug related SMR (95% CI)
Amin [12] (2006) Australia HCV mono-infected 3.1 (3.0-3.2) 16.8 (15.4-18.3) 19.3 (18.1-20.5)
HCV/HBV co-infected 5.6 (4.8-6.6) 32.9 (23.1-46.7) 24.7 (18.2-33.5)
Duberg [13] (2008) Sweden HCV mono-infected 5.8 (5.6-6.0) 35.5 (32.9-38.3) 20.7 (18.9-22.7)
HCV/HBV co-infected 8.5 (7.3-9.8) 46.2 (31.5-62.3) 27.6 (19.6-39.6)
McDonald [15] (2008) Scotland HCV mono-infected 4.9 (4.6-5.1) 20.0 (17.9-22.2) 23.5 (21.3-25.7)
HCV/HIV co-infected 32.9 (29.2-37.0) 34.8 (23.3-50.0) 36.6 (25.2-51.4)
Yu (2012) Canada All HCV-infected 4.8 (4.6-5.0) 23.7 (21.9-25.7) 20.7 (19.1-22.5)
REAC 4.7 (4.5-4.9) 23.9 (22.0-26.0) 19.9 (18.3-21.7)
SERO 10.1 (8.4-12.1) 14.8 (6.4-29.1) 36.7 (27.1-48.5)

SMR=standardized mortality ratio; HCV=hepatitis C virus; HBV=hepatitis B virus; HIV=human immunodeficiency virus; REAC=reactive at first test; SERO=seroconverter.

Yu et al.

Yu et al. BMC Public Health 2013 13:291   doi:10.1186/1471-2458-13-291

Open Data